Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

305.95
+2.180.72%
Volume:355.38K
Turnover:108.80M
Market Cap:39.89B
PE:-145.81
High:308.93
Open:303.22
Low:302.34
Close:303.77
Loading ...
Jun 02, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 13, 2025

Major Issues Report

Form 8-K - Current report
May 01, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 01, 2025

Major Issues Report

Form 8-K - Current report
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]